Chemo and immunotherapy together may help triple-negative breast cancer patients
New research is bringing hope to women with a hard-to-treat type of breast cancer. A study published over the weekend in the New England Journal of Medicine found that combining chemotherapy with an immunotherapy medicine added up to 10 months of survival time for patients with triple-negative breast cancer. Dr. David Agus joins "CBS This Morning" with more on the research.
Subscribe to the "CBS This Morning" Channel HERE: http://bit.ly/1Q0v2hE
Watch "CBS This Morning" HERE: http://bit.ly/1T88yAR
Watch the latest installment of "Note to Self," only on "CBS This Morning," HERE: http://cbsn.ws/1Sh8XlB
Follow "CBS This Morning" on Instagram HERE: http://bit.ly/1Q7NGnY
Like "CBS This Morning" on Facebook HERE: http://on.fb.me/1LhtdvI
Follow "CBS This Morning" on Twitter HERE: http://bit.ly/1Xj5W3p
Follow "CBS This Morning" on Google+ HERE: http://bit.ly/1SIM4I8
Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T
Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8
Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B
Delivered by Norah O’Donnell and Gayle King, "CBS This Morning" offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for "CBS This Morning" broadcast times.
-
Category
No comments found